Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$4.56
+1.56%
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+119.3%
Consensus $10.00 vs current $4.56
NASDAQ·Healthcare·Biotechnology
$4.56
+1.56%
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+119.3%
Consensus $10.00 vs current $4.56